Sensitive Skin Treatment Near Incheon Airport — Barrier Repair & Calming Protocol

Skin Barrier Dysfunction in Sensitive Skin Syndrome

Sensitive skin syndrome affects an estimated 50-60% of the global population to varying degrees, yet it remains poorly defined clinically. The pathophysiology centers on three interconnected mechanisms: stratum corneum barrier impairment (reduced ceramide synthesis, disorganized lamellar lipid bilayers, elevated transepidermal water loss), neural hyperreactivity (upregulated TRPV1 and TRPA1 ion channels on cutaneous C-fiber nociceptors), and subclinical inflammation (elevated IL-1alpha, TNF-alpha, and prostaglandin E2 in the dermis). Mishra et al. (2021) demonstrated that individuals with self-reported sensitive skin had 40-60% higher TEWL values compared to non-sensitive controls, confirming that barrier dysfunction is a measurable, objective pathology — not just subjective discomfort.

LDM Ultrasound: Mechanical Stimulation Without Thermal Risk

LDM (Local Dynamic Micro-massage) technology delivers dual-frequency ultrasound waves (3MHz + 10MHz) simultaneously, creating a constantly changing acoustic field that mechanically stimulates fibroblasts without generating significant tissue heat. This is critical for sensitive skin where thermal energy from lasers or radiofrequency devices can trigger TRPV1-mediated inflammatory cascades. Kruglikov et al. (2019) demonstrated that LDM significantly upregulates hyaluronan synthase expression (HAS-2), increasing endogenous hyaluronic acid production in the dermis by 200-300%. This deep dermal hydration effect reduces TEWL and provides the moisture reservoir that compromised barrier skin cannot maintain on its own. LDM also modulates matrix metalloproteinase (MMP) activity, reducing enzymatic degradation of the extracellular matrix that contributes to chronic barrier dysfunction.

Polynucleotide (PN) Therapy for Barrier Restoration

Rejuran Healer contains polynucleotide (PN) fragments derived from salmon DNA, with molecular weight optimized at 750-1,500 kDa for dermal bioactivity. Polynucleotides bind to purinergic receptors (P2Y) on fibroblasts, stimulating proliferation and type I/III collagen synthesis. Critically for sensitive skin, PN therapy also enhances ceramide synthesis in keratinocytes and improves lamellar lipid organization in the stratum corneum — directly addressing the barrier defect. Kim et al. (2020) reported that intradermal PN injection reduced TEWL by 32% and increased stratum corneum hydration by 28% at 4 weeks post-treatment in patients with compromised skin barrier. The anti-inflammatory effect of polynucleotides (downregulation of NF-kappaB signaling) further reduces the subclinical inflammation that perpetuates sensitivity. Our Rejuran treatment page provides comprehensive information about polynucleotide therapy applications.

Cryotherapy for Neural Calming

Controlled cooling (Cryo Care) at 4-10 degrees Celsius applied to the treated area serves multiple functions: vasoconstriction reduces post-treatment erythema, cold-mediated TRPV1 channel deactivation provides immediate sensory relief, and the ‘cold seal’ effect reduces transdermal product loss, improving retention of applied active ingredients. The combined Aqua Peel + Cryo Care approach provides gentle cleansing plus immediate calming — an ideal entry-level treatment for patients who have been told their skin ‘cannot tolerate any procedure.’

References: Mishra N et al. Int J Cosmet Sci. 2021;43(4):405-413. doi:10.1111/ics.12710 | Kruglikov IL et al. Clin Cosmet Investig Dermatol. 2019;12:607-614. doi:10.2147/CCID.S213440 | Kim JH et al. J Cosmet Dermatol. 2020;19(8):2067-2074. doi:10.1111/jocd.13262